vimarsana.com

தொழில்நுட்பம் ஆஃப் தி மக்கள் குடியரசு சீனா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Oxygen-vacancy-mediated Catalysis Boosts Direct Methanation of Biomass

Chinese Academy of Sciences Biomethane (CH Currently, CH 4 is mainly produced via a multi-step process in which biomass is first gasified into biogas, followed by the methanation of the latter. This method requires high temperature and pressure and shows low selectivity for chemical or biological processes. Recently, a research group led by Prof. WANG Feng from the Dalian Institute of Chemical Physics of the Chinese Academy of Sciences, in collaboration with Prof. WANG Min’s group from Dalian University of Technology, proposed interfacial oxygen-vacancy (Vo)-mediated catalysis over Ru/TiO 2 for the direct methanation of lignocellulosic biomass at temperatures below 200°C and with a selectivity above 95%.

The Expo 2020 Dubai joined Hands with Terminus Group at the Pujiang Innovation Forum, a showcase of Cutting-Edge Innovative Technologies

Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults

See eTable 1 in Supplement 2 for definitions of each analysis population. Among those receiving aluminum hydroxide (alum) for the first dose, 5 participants received WIV04 (n = 2) and HB02 (n = 3) vaccines for the second dose and were not included in the safety analysis population of the alum-only group (13 458 – 5 = 13 453), but were included in the WIV04 and HB02 groups, respectively. Three participants who received WIV04 for the first dose and HB02 for the second dose and 3 participants who received HB02 for the first dose and WIV04 for the second dose were included in both groups (WIV04: 13 459 + 2 + 3 = 13 464; HB02: 13 465 + 3 + 3 = 13 471). To measure neutralization antibody levels, the first 900 participants from each study site were selected. There were 9 participants in the WIV04 group, 7 in the HB02 group, and 8 in alum-only group who had adverse events or serious adverse events (SAEs) after the first dose and did not receive the secon

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.